TrialChinese medical journal2015

Does Early Postsurgical Temozolomide Plus Concomitant Radiochemotherapy Regimen Have Any Benefit in Newly-diagnosed Glioblastoma Patients? A Multi-center, Randomized, Parallel, Open-label, Phase II Clinical Trial.

Ying Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.